The invention provides a recombinant cluster and application, the recombinant cluster comprises an
amino acid primary sequence for coding the recombinant cluster, the
amino acid primary sequence is at least 95% homologous with any one of SEQ ID NO.1-17, and a
tertiary structure formed by the
amino acid primary sequence does not have a
disulfide bond. The recombinant cluster provided by the invention can greatly improve the yield of purification after
escherichia coli expression, simplifies the production process, and realizes industrial large-scale production; the space structure of the recombinant cluster is free of artificially added sequences or structures, so that
immunogenicity reaction is not easily induced, no other toxic or
side effect exists, and the
druggability is strong; in animal experiments, heat aggregation of
protein can be inhibited, an obvious protection effect on
oxidative stress of HCE-T cells is achieved, a new choice is provided for treatment of various animal diseases, and the good clinical application value is achieved.